EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Activity of Halogenated Compounds Derived from L-Tyrosine Against SARS-CoV-2

Paula A Velásquez-Bedoya, María I Zapata-Cardona iD, Laura M Monsalve-Escudero iD, Jaime A Pereañez iD, Diego Guerra-Arias iD, Manuel Pastrana-Restrepo, Elkin Galeano iD, Wildeman Zapata-Builes iD

Molecules · 2025

DOI: 10.3390/molecules30071419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Paula A Velásquez-Bedoya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Calle 50 # 40-74, Medellín 050001, Colombia. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Tyrosine, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Cooperativa de Colombia and Universidad de Antioquia, UdeA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Currently, there are no effective medications for treating all the clinical conditions of patients with COVID-19. We aimed to evaluate the antiviral activity of compounds derived from L-tyrosine against the B.1 lineage of SARS-CoV-2 in vitro and in silico. Methodology: The cytotoxicities of 15 halogenated compounds derived from L-tyrosine were evaluated in Vero-E6 cells by the MTT assay. The antiviral activity of the compounds was evaluated using four strategies, and viral quantification was performed by a plaque assay and qRT-PCR. The toxicity of the compounds was evaluated by ADMET predictor software. The affinity of these compounds for viral or cellular proteins and the stability of their conformations were determined by docking and molecular dynamics, respectively.

Results

TODC-3M, TODI-2M, and YODC-3M reduced the viral titer >40% and inhibited the replication of viral RNA without significant cytotoxicity. In silico analyses revealed that these compounds presented low toxicity and binding energies between −4.3 and −5.2 Kcal/mol for three viral proteins (spike, Mpro, and RdRp). TODC-3M and YODC-3M presented the most stable conformations with the evaluated proteins.

Conclusions

The most promising compounds were TODC-3M, TODI-2M, and YODC-3M, which presented low in vitro and in silico toxicity, antiviral potential through different strategies, and favorable affinities for viral targets. Therefore, they are candidates for in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2TyrosineCOVID-19 Drug TreatmentChlorocebus aethiopsVero CellsAnimalsMolecular Docking SimulationHumansMolecular Dynamics SimulationVirus ReplicationCOVID-19HalogenationSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID-19L-tyrosineSARS-CoV-2antiviral activityhalogenated compounds

Substanzen

Antiviral AgentsTyrosineSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Calle 50 # 40-74, Medellín 050001, Colombia.
  • Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Medellín 050001, Colombia.
  • Grupo de Investigación Promoción y Prevención Farmacéutica, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, Medellín 050001, Colombia.
  • Instituto de Parasitología y Biomedicina "López-Neyra", Consejo Superior de Investigaciones Científicas, PTS Granada, 18016 Granada, Spain.
  • Programa de Estudio y Control de Enfermedades Tropicales PECET, Facultad de Medicina, Universidad de Antioquia, Medellín 050010, Colombia.
  • Grupo Productos Naturales Marinos, Departamento de Farmacia, Facultad de Ciencias Farmacéuticas y Alimentarias, Universidad de Antioquia UdeA, Medellín 050001, Colombia.

ORCID-Profile: María I Zapata-Cardona, Laura M Monsalve-Escudero, Jaime A Pereañez, Diego Guerra-Arias, Elkin Galeano, Wildeman Zapata-Builes

Förderung

  • Universidad Cooperativa de Colombia and Universidad de Antioquia, UdeA

Zitieren

APA

Velásquez-Bedoya, P. A., Zapata-Cardona, M. I., Monsalve-Escudero, L. M., Pereañez, J. A., Guerra-Arias, D., Pastrana-Restrepo, M., Galeano, E., & Zapata-Builes, W. (2025). Antiviral Activity of Halogenated Compounds Derived from L-Tyrosine Against SARS-CoV-2. Molecules. https://doi.org/10.3390/molecules30071419

Vancouver

Velásquez-Bedoya PA, Zapata-Cardona MI, Monsalve-Escudero LM, Pereañez JA, Guerra-Arias D, Pastrana-Restrepo M, et al. Antiviral Activity of Halogenated Compounds Derived from L-Tyrosine Against SARS-CoV-2. Molecules. 2025. doi:10.3390/molecules30071419

BibTeX
@article{VelsquezBedoya2025,
  author = {Velásquez-Bedoya, Paula A and Zapata-Cardona, María I and Monsalve-Escudero, Laura M and Pereañez, Jaime A and Guerra-Arias, Diego and Pastrana-Restrepo, Manuel and Galeano, Elkin and Zapata-Builes, Wildeman},
  title = {Antiviral Activity of Halogenated Compounds Derived from L-Tyrosine Against SARS-CoV-2},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30071419}
}
Kostenlos starten →